Actavis to pay $202M in Medicaid overbilling settlements

Actavis has agreed to pay $118 million to settle claims that the U.S. government and four states overpaid for its drugs. The deal follows an $84 million settlement of similar claims filed by the state of Texas. Report

Suggested Articles

New real-world data from Lilly and BI show their SGLT2 med Jardiance topped GLP-1s at preventing heart failure hospitalization.

Following its headline-grabbing presentation at ESC, AZ is out with more data that support Farxiga use in non-diabetic heart failure patients.

An online pharmacy has again criticized FDA action after tipping off regulators to the existence of a dangerous impurity in Zantac and other antacids.